Literature DB >> 10579312

Partial characterization of circulating inhibin-B and pro-alphaC during development in the male rhesus monkey.

S J Winters1, T M Plant.   

Abstract

Gel filtration chromatography and ELISAs for inhibin-B and pro-alphaC were used to examine the circulating forms of inhibin in the neonatal (age 2-6 weeks), juvenile (age 1-2 yr), and adult male rhesus monkey. In all samples, isoforms of inhibin-B of 26-36K and 150K were found. Both forms were significantly greater in the adult. The alpha-subunit assay detected major peaks at 45-60 and 29-31K, and a minor peak of greater than 100K. As for inhibin-B, the major forms of inhibin pro-alphaC were highest in adulthood. Inhibin-B and pro-alphaC were measurable in peripheral plasma at age 1 week, increased with the neonatal rise in plasma FSH, and then decreased but remained detectable through age 1 yr. Values in adult males were higher than at any time during the first year of life. Finally, mean values of plasma inhibin-B and pro-alphaC in five monkeys, based on multiple blood samples drawn between age 1 week and 1 yr, were rank ordered and were found to be highly positively correlated (r = 0.96), suggesting that inhibin levels in the first year of life may be a marker of Sertoli cell number, and may predict the spermatogenic capacity of the testis in adulthood.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10579312     DOI: 10.1210/endo.140.12.7167

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  2 in total

Review 1.  Inhibin at 90: from discovery to clinical application, a historical review.

Authors:  Yogeshwar Makanji; Jie Zhu; Rama Mishra; Chris Holmquist; Winifred P S Wong; Neena B Schwartz; Kelly E Mayo; Teresa K Woodruff
Journal:  Endocr Rev       Date:  2014-07-22       Impact factor: 19.871

2.  Cloning of a novel inhibin alpha cDNA from rhesus monkey testis.

Authors:  Daniel J Bernard; Teresa K Woodruff; Tony M Plant
Journal:  Reprod Biol Endocrinol       Date:  2004-10-07       Impact factor: 5.211

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.